Oculis Holding AG (OCS) Interest Coverage Ratio (2022 - 2026)
Quarterly Interest Coverage Ratio fell 4.7% to 1.21 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.01 through Mar 2026, down 178.5% year-over-year, with the annual reading at 1.44 for FY2025, 34.08% down from the prior year.
Oculis Holding AG's Interest Coverage Ratio history spans 5 years, with the latest figure at 1.21 for Q1 2026.
- Interest Coverage Ratio came in at 1.21 for Q1 2026, up from 1.71 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.0 in Q3 2024 to a low of 19.91 in Q3 2023.
- The 5-year median for Interest Coverage Ratio is 1.18 (2025), against an average of 4.02.
- Year-over-year, Interest Coverage Ratio plummeted 17975.88% in 2023 and then skyrocketed 100.0% in 2024.
- Oculis Holding AG's Interest Coverage Ratio stood at 0.16 in 2022, then plummeted by 9430.96% to 15.42 in 2023, then surged by 99.92% to 0.01 in 2024, then tumbled by 13941.08% to 1.71 in 2025, then rose by 29.16% to 1.21 in 2026.
- Per Business Quant, the three most recent readings for OCS's Interest Coverage Ratio are 1.21 (Q1 2026), 1.71 (Q4 2025), and 0.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 49.84 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 11.50 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 3.88 |
| 10 | Oculis Holding AG | 24.51 Bn | 24.21 Bn | - | -1.21 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.21 |
| Dec 31, 2025 | -1.71 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | -1.43 |
| Mar 31, 2025 | -1.15 |
| Dec 31, 2024 | -0.01 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | -2.82 |
| Mar 31, 2024 | -5.41 |
| Dec 31, 2023 | -15.42 |
| Sep 30, 2023 | -19.91 |
| Jun 30, 2023 | -14.71 |
| Mar 31, 2023 | -0.18 |
| Dec 31, 2022 | -0.16 |
| Sep 30, 2022 | -0.11 |
| Jun 30, 2022 | -0.14 |